{
    "Orphapacket": {
        "ORPHApacketId": "97560",
        "creationDate": "2025-06-26 11:48:15",
        "version": "1.3.42 / 4.1.8 [2025-03-03]",
        "copyright": "Orphanet (c) 2025",
        "ORPHAcode": "97560",
        "Label": "Primary membranous glomerulonephritis",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_97560",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "Synonyms": [
            {
                "Synonym": "Primary membranous nephropathy"
            },
            {
                "Synonym": "Idiopathic membranous glomerulonephritis"
            }
        ],
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "614692",
                "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A rare glomerular disease histologically characterized by thickening of the capillary wall with immune deposits predominantly containing IgG4 and C3 on the sub-epithelial side and typically manifesting with nephrotic syndrome."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "93548",
                        "Label": "Glomerular disease"
                    }
                ]
            }
        ],
        "Phenotypes": [
            {
                "Phenotype": {
                    "HPOId": "HP:0034002",
                    "HPOTerm": "Anti-phospholipase A2 receptor antibody positivity",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "21068142[PMID]_ORPHANET",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            },
            {
                "Prevalence": {
                    "Source": "21068142[PMID]_ORPHANET",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            },
            {
                "Prevalence": {
                    "Source": "21068142[PMID]_34593809[PMID]_ORPHANET",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "Unknown",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            }
        ],
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "Adult"
                }
            ]
        }
    }
}